AFIB Acutus Medical

Acutus Medical to Cancel Third Quarter 2023 Conference Call

Acutus Medical to Cancel Third Quarter 2023 Conference Call

CARLSBAD, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced that, following the Company’s announcement of its strategic realignment of resources and corporate restructuring and release of its third quarter results on November 8, 2023, the Company will no longer hold its third quarter results conference call and webcast which was previously scheduled for Monday, November 13, 2023.

About Acutus Medical, Inc.

Acutus is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. Founded in 2011, Acutus is based in Carlsbad, California.



Investor Contact:
Chad Hollister

Acutus Medical, Inc.
D: 442-232-6080


EN
10/11/2023

Underlying

AFIBAcutus Medical

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Acutus Medical

 PRESS RELEASE
Free
AFIB ACUTUS MEDICAL

Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial ...

Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results CARLSBAD, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the second quarter and year-to-date of 2024. Recent Highlights: Second quarter revenue from Continuing Operations of $4.1 million grew 172% year-over-year, from $1.5 million in the same quarter last year.Operating expenses for continuing operations were $2.2 million, a reduction of 47% compared to the same period last year.Recorded $2.9 million in gain on sale of business,...

August 8, 2024 1 EN
 PRESS RELEASE
Free
AFIB ACUTUS MEDICAL

Acutus Medical Reports First Quarter 2024 Financial Results

Acutus Medical Reports First Quarter 2024 Financial Results CARLSBAD, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the first quarter of 2024. Recent Highlights: First quarter revenue from Continuing Operations of $3.6 million grew 192% year-over-year, from $1.2 million in the same quarter last year..Operating expenses for continuing operations were $3.3 million, a reduction of 38% compared to the same period last year.Recorded $2.8 million in gain on sale of business, an increase of 131% compared to ...

May 9, 2024 1 EN
 PRESS RELEASE
Free
AFIB ACUTUS MEDICAL

Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Res...

Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the fourth quarter and full year ended December 31,2023. Recent Highlights: Announced strategic realignment of resources and corporate restructuring on November 8, 2023 with the objective of optimizing financial position and maximizing free cash flow.The Continuing Operations focuses on the implementation of the business model to shift to solely support the manufacturing ...

April 1, 2024 1 EN
 PRESS RELEASE
Free
AFIB ACUTUS MEDICAL

Acutus Medical to Cancel Third Quarter 2023 Conference Call

Acutus Medical to Cancel Third Quarter 2023 Conference Call CARLSBAD, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced that, following the Company’s announcement of its strategic realignment of resources and corporate restructuring and release of its third quarter results on November 8, 2023, the Company will no longer hold its third quarter results conference call and webcast which was previously scheduled for Monday, November 13, 2023. About Acutus Medical, Inc.Acutus is focused on the production of left-heart ac...

November 10, 2023 1 EN
 PRESS RELEASE
Free
AFIB ACUTUS MEDICAL

Acutus Medical Reports Third Quarter 2023 Financial Results

Acutus Medical Reports Third Quarter 2023 Financial Results CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the third quarter of 2023. Recent Highlights: Third quarter revenue of $5.2 million grew 44% year-over-year, led by strong growth in distribution revenue from sales of left-heart access products to MedtronicRegistered significant year-over-year reductions in both GAAP and non-GAAP operating expenses and cash burn, resulting from disciplined focus on expense managementAnnounced strategic ...

November 8, 2023 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch